ArticleBiomarker research2025

MORF4L2 induces immunosuppressive microenvironment and immunotherapy resistance through GRHL2/MORF4L2/H4K12Ac/CSF1 axis in triple-negative breast cancer.

Xin-Yi Sui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.